SCHEMBL8947009

SCHEMBL8947009

CC(C)CCc1ccccc1Oc1cccc(CCCC(P(=O)(O)O)S(=O)(=O)O)c1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 13/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8625373 0.91 FDFT1 (0.56) FDFT1
SCHEMBL8947028 0.90 FDFT1 (0.56) FDFT1
SCHEMBL8618807 0.90 FDFT1 (0.56) FDFT1
SCHEMBL1238004 0.88 FDFT1 (0.71) FDFT1
Potassium SCHEMBL412416 0.87 FDFT1 (0.70) FDFT1
SCHEMBL8618690 0.87 FDFT1 (0.52) FDFT1
SCHEMBL412414 0.87 FDFT1 (0.70) FDFT1
SCHEMBL8620459 0.86 FDFT1 (0.60) FDFT1
SCHEMBL8621528 0.86 HTR2A (0.40) FDFT1
SCHEMBL8623431 0.85 FDFT1 (0.54) FDFT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US claimed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
EP-0595635-A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors E.R. Squibb & Sons, Inc. (US) 1994-05-04 EP disclosed